ArticleAging2024

Bezafibrate mitigates cardiac injury against coronary microembolization by preventing activation of p38 MAPK/NF-κB signaling.

Ruijie Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.